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ABSTRACT
Repetitive mechanical stimulation of differentiated skeletal
muscle in tissue culture increases the production of prostaglandin
F2., an anabolic stimulator of myofiber growth. Within 4 h of
initiating mechanical activity, the activity of cyclooxygenase, a
regulatory enzyme in prostaglandin synthesis, was increased 82%
(P<.005), and this increase was maintained for at least 24 h.
Kinetic analysis of the stretch-activated cyclooxgenase indicated
a two to three-fold decrease in the enzyme's K. with no change in
VMx. The stretch-induced increase in enzymatic activity was not
inhibited by cycloheximide, was independent of cellular electrical
activity (tetrodotoxin-insensitive), but was prevented by the G
protein inhibitor pertussis toxin. Pertussis toxin also inhibited
the stretch-induced increases in PGF2= production, and cell growth.
It is concluded that stretch of skeletal muscle increases the
synthesis of the anabolic modulator PGF2_ by a G protein-dependent
process which involves activation of cyclooxgenase by a
posttranslational mechanism.
Keywords: prostaglandin GH synthase; stretch; protein synthesis;
growth; G proteins.
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INTRODUCTION
Prostaglandins (PGs) are important regulators of skeletal
muscle growth both during development and in the adult animal
[reviewed in (19)]. PGEI stimulates myoblast fusion into
multinucleated myofibers (3,7,17) while PGE2 and PGF2. regulate
skeletal muscle protein turnover rates (22,23,29,34). Skeletal
muscles synthesize and efflux prostaglandins such as PGEI, PGE2, and
PGF2_ i_nnvivo (40,42), in organ culture (20,22), and in tissue
culture (15,34), and these compounds act as both autocrine and
paracrine growth modulators in this tissue. The mechanism by which
PGs regulate skeletal muscle growth is not known.
Increased passive muscle tension induced by stretch is an
important growth stimulus in skeletal muscle, while decreased
tension from muscle shortening leads to muscle atrophy (31). PGs
have been shown to act as autocrine/paracrine second messengers in
regulating stretch/tension-induced muscle protein turnover rates i__nn
vivo (9,18), and i_nn vitro (20,27,34). Repetitive mechanical
stimulation of tissue cultured skeletal muscle cells at specific
frequencies results in an increase in the production of PGE2 and
PGF2. while the stable derivative of prostacyclins (6 keto - PGFIa)
is not altered (34). Increased PGE2 synthesis in the cultured
muscle cells occurs within 4-6 h after initiating mechanical
activity, returns to baseline levels by 24 h, and is associated
with initial muscle damage (34). PGF2. synthesis increases by 24 h
of continued mechanical stimulation, is maintained at elevated
levels for days, and is associated with long term stretch-induced
muscle cell growth (34). These data are compatible with the notion
that PGE2 stimulates catabolic processes while PGF2_ stimulates
anabolic processes in skeletal muscle (22,23).
There are two main mechanisms which control the synthesis
rates of PGs - activity of the various phospholipases which provide
the immediate precursor arachidonic acid for prostaglandin
synthesis (8), and the activity of the enzyme which converts
arachidonic acid into PGs, prostaglandin endoperoxide synthase, EC
1.14.99.1 [also called cyclooxgenase (2)]. Mechanical stimulation
of the cultured skeletal muscle cells increases the breakdown rate
of arachidonic acid-containing phospholipids by activating
phospholipases A2 and D but not phosphatidylinositol specific
phospholipase C (38). In this paper, we examined whether stretch
also increases cyclooxgenase activity, the second regulatory step
in PG synthesis. Cyclooxygenase is a rapidly turning over protein
with a half-life of 60 minutes in fibroblasts (21) and less than i0
min in skeletal muscle (4). One isoform of cyclooxgenase (mitogen-
inducible) is an immediate early gene product activated at the
transcriptional level during growth factor-stimulated cell growth
(5,26,41). We show in this paper that mechanical stimulation of
tissue cultured skeletal muscle cells increases cyclooxgenase
activity by a posttranslational, G-protein dependent mechanism. The
mitogen-inducible, immediate early gene isoform of cyclooxygenase
was immunocytochemically localized to the skeletal myofibers but
its contribution to total enzymatic activity in the stretch-
stimulated skeletal muscle cultures is not presently known. Parts
of this work have appeared in abstract form C39).
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MATERIALS AND METHODS
Cell Cultures
Avian myoblasts
pectoralis muscle by
were isolated from 11-12 days in ovo
standard dissection techniques (35).
Fertilized chicken eggs were obtained from Beaver River Farm (West
Kingston, RI). The isolated cells were plated at a very high
density of 5,700-7,900 cells/mm 2 in 1 ml of growth medium and
maintained in a humidified 5.0% CO2 incubator at 37°C. Growth
medium was Eagle's basal medium containing 50 U/ml penicillin, 10%
horse serum, and 5% chicken embryo extract (85/10/5 medium), and
was changed every 24 h. Cells were plated and grown in culture
wells of a Mechanical Cell Stimulator device (Cell Kinetics, Inc.,
P.O. Box 40643, Providence, RI 02940) described previously (33)
with minor modifications. The cell growth chamber of the modified
Mechanical Cell Stimulator (Figure IA) was made of stainless steel
and contains 36 - 15 mm diameter teflon-lined culture wells. Use of
stainless steel for the cell growth chamber rather than the
previously used teflon material allowed rapid sterilization of the
chamber by autoclaving rather than by gas sterilization. Sandwiched
between the two halves of the cell growth chamber was a collagen-
coated (Type I, Collaborative Research, Bedford, MA) elastic
membrane (0.01" thick SILASTIC TM, Dow Corning, Corp., Midland, MI)
to which the muscle cells attach and grow. A circular piece of
stainless steel wire cloth was located around the periphery of each
well and acted as an "artificial tendon" by providing a surface to
which the differentiating cells attach and are stretched (Figure
IB). At 48-54 h postplating, the newly formed multinucleated
myofibers were embedded in a Type I collagen gel matrix as
described previously to strengthen the cells for subsequent
mechanical stimulation (6). By Day 7-8 postplating, the cultures
consisted of a thin 10-50 Bm thick "diaphragm-like" multilayer of
cells containing a high density of well-striated, spontaneously
contracting neonatal-like myofibers, unfused myoblasts, and
interstitial fibroblasts. Approximately forty percent of the total
culture nuclei were in unfused myoblasts and interstitial
fibroblasts while 85-90% of the total noncollagenous protein in the
cultures was located in the much larger multinucleated skeletal
myofibers (33). The fibroblasts are essential in the culture model
system to integrate the myofibers with the extracellular matrix
material to form an organ-like tissue capable of being subjected to
long-term mechanical stimulation without detachment or long-term
damage (6).
Mechanical Stimulation
Day 7-8 muscle cultures were mechanically stimulated in a
37°C, 5% C02 incubator by placing the cell growth chamber above a
computer controlled stepper motor attached to a moveable prong
plate as described previously (32). Prior to mechanical
stimulation, the cells were rinsed extensively over a 1-2 h period
with Eagle's basal medium and then incubated with 0.5 ml/well of
either Eagle's basal medium only or supplemented with bovine serum
albumin (0.5 g/L), selenous acid (4.0 _g/L) and ferrous sulfate
(0.8 mg/L). Results in both media were similar. Two mm diameter
prongs positioned below 18 of the 36 culture wells place a radial
stretch on the cell layer when they move upward, and the cell layer
returns to its initial position when the prongs move downward
(Figure IC). The cells were repetitively stretched and relaxed by
the prong/stepper motor assembly using a software activity program
which was shown previously to optimally increase PG synthesis in
the muscle cells (34). The rounded prongs used in the modified
mechanical cell stimulator place a Donu_iform stretch on the cells,
with the greatest stretch in the center of each well and the least
stretch near the periphery. For example, in the activity program
used in the present experiments (TRIAL 51.PGM), the prong moves up
and down by 5 mm and the substratum stretches and relaxes by 25% in
the inner third, 10% in the middle third, and 6% in the outer third
of each well (mean stretch of all areas equals 12%). The cells are
stretched and relaxed five times during a 20 s period followed by
a i0 s rest; this activity is repeated twice more and is followed
by a 15 min rest period (Figure ID). The cells_ are thus
mechanically stimulated for 6_7% of the experimental time. The rate
of prong movement is 2.5 mm/s. In experiments where the percent
stretch was varied from 2-23%, prong distance movement was varied
in the same experiment by using prongs of different heights.
Unstimulated controls were maintained in the same setup and on the
same elastic substratum as the cells that were mechanically
stimulated. The setup was placed on a rotary shaker (20-40 rpm) to
eliminate any medium stirring differences between the control and
stretch groups. All experiments were repeated with at least two
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different preparations of primary muscle cells.
Biochemical Assays
PGE2 and PGF2_ levels in the medium (the major eicosanoids
produced by these cells) were measured using commercial
radioimmunoassay kits (Advanced Magnetics, Cambridge, MA) as
outlined previously (34) or by ELISA (PGF2_ only, Cayman Chemical
Co., Ann Arbor, MI). The cross reactivity of the RIA antibodies at
50% binding (B)/initial binding (Bo) ratio were PGE 2 antibody: 1.3%
for PGF2_, <1.0% for 6-keto-PGF_; PGF2. antibody, <0.3% for PGE2,
<2.0% for 6-keto-PGF1,. In the ELISA assay, PGF2_ cross-reacted <0.1%
with PGE2 and <2% with 6-keto-PGF_.
Cyclooxgenase (prostaglandin GH synthase) activity was assayed
i__nnsit_ (24) b following the conversion of exogenously added
arachidonic acid to PGE2 or PGF2_. Activity was measured by adding
30 _M arachidonic acid to the culture medium (Eagle's basal medium)
of the cells for 30 min at 37°C as described by Rosen et al (24).
The concentration of newly synthesized PGF2_ in the medium after
this 30 min incubation was assayed by either RIA or ELISA as
outlined above. Without exogenous arachidonic acid, no PGF2. was
detected in the cells' culture medium after 30 min, and incubation
of the arachidonic acid containing medium for 30 min at 37°C in the
absence of cells did not lead to PGF2. formation (data not shown).
Similar results were obtained if PGE2 was assayed.
Total noncollagenous protein content was measured by the
bicinchoninic acid protein assay (Pierce Chemical Co., Rockford,
IL) as described previously (33). All other chemicals were reagent
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grade and purchased from Sigma Chemical Co. (St. Louis, MI).
Morphometric Measurements
Cells were stained after fixation in either ethanol:acetic
acid (2:l,v/v) for hematoxylin-eosin staining, or -20 ° methanol for
enzyme immunocytochemistry using a monoclonal antibody specific for
avian embryonic fast myosin heavy chain (EBI65) [kindly provided by
Dr. Everett Bandman] together with avidin-biotinylated secondary
antibody reaction coupled to horseradish peroxidase (Vectastain
ABC, Vector Labs., Burlingame, CA). The fixed and stained cells
were coverslipped, and observed under a Zeiss light microscope. For
cyclooxgenase immunocytochemical staining, cells were fixed in 3.7%
formaldehyde for i0 min and stained using either polyclonal rabbit
anti-mammalian cyclooxygenase antibody against the constitutive
isoform (Oxford Biomedical, PG20) or polyclonal rabbit anti-chicken
cyclooxygenase antibody against the mitogen-inducible isoform
(Oxford Biomedical, PG25).
All data were analyzed statistically by PCStatistician
software (Human Systems Dynamics, Northridge, CA).
9
RESULTS
Intermittent mechanical stimulation of differentiated myofiber
cultures in the modified mechanical cell stimulator for 24 h
significantly increased PGF2_production as previously reported for
the original system (34,38). In three separate experiments, the
percent stretch-induced increase in PGF2_efflux after 24 h varied
between 45% and 173% with different cell preparations as previously
found (34). Twelve to fifteen percent repetitive cell stretches
were found to be optimal for increased PGF2.production and percent
stretches less than or greater than this were not as effective
(Figure 2). These results are similar to those reported elsewhere
(34).
The muscle cultures contain two main cell types,
multinucleated striated myofibers and interstitial fibroblasts.
Cyclooxgenase specific antibodies were used to identify the
cyclooxygenase isoform and cell type in which the enzyme is
located. Staining with antibody PG20 which is specific for the
constitutive isoform of cyclooxgenase gave very weak general
staining of both myofibers and fibroblasts (data not shown), while
antibody PG25 which is specific for the mitogen-inducible isoform
of cyclooxgenase stained much more intensely and specifically
stained the cytoplasm of the differentiated myofibers without any
indication of fibroblast staining (Figure 3). PG25 antibody diluted
i:i00 reacted with a single protein band in avian muscle culture
extracts on Western blots while the PG20 antibody did not detect
any protein bands at a i:i00 dilution (data not shown).
i0
To determine whether the stretch-induced increase in PGF2_
production resulted from altered cyclooxgenase activity, enzymatic
activity was measured in intact cells by adding 30 _M exogenous
arachidonic acid during the last 30 min of mechanical activity.
Control experiments indicated that PGF2_synthesis from exogenously
added arachidonic acid was linear for at least 60 min (Figure 4
upper left insert) and a 30 BM concentration was found to optimally
stimulate PGF2_ synthesis (Figure 4, upper right insert).
Cyclooxygenase activity in the cultured muscle cells by this assay
represents true enzyme activity since it is inhibitable by three
well-known cyclooxgenase inhibitors - indomethacin, aspirin, and
ibuprofen (Figure 4, lower insert). Intermittent mechanical
stimulation for either 4-5 h or 24 h significantly increased
cyclooxgenase activity compared to static controls (Figure 4).
After 4-5 h of mechanical stimulation by TRIAL51.PGM, cyclooxgenase
activity was increased 98% (P<.003) and by 178% (P<.O02) after 24
h. Similar results were obtained in two additional experiments with
different cell preparations (data not shown).
For kinetic analysis of the _ stretch-induced increase in
cyclooxygenase activity, the cells were mechanically stimulated for
4 or 24 h and incubated with 5-50 _M exogenous arachidonic acid
during the last 30 min of the experiment. PGF2. production was
assayed from an aliquot of the medium. Plotting the data as double
reciprocal plots and calculating K_ and V... values for
cyclooxygenase indicated that stretch-induced increases in enzyme
activity at both time points were due to a two-to-three-fold
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decrease in the K. with little effect on the enzyme's V.a_ (Figure
5).
To determine whether protein synthesis was required for the
stretch-induced increase in cyclooxygenase activity, the stretch
experiments were repeated in the presence of 70 BM cycloheximide.
This concentration of cycloheximide inhibited total protein
synthesis rates by 87-92%, based on reduced incorporation of 14C-
phenylalanine into trichloroacetic acid precipitable material (data
not shown). Total noncollagenous cellular protein levels were
reduced 12% after 4-5 h in cycloheximide (mean _ S.E.: 363 ± 26 vs.
321 ± 33 _g/well, p < .04) and 33% after 20-22 h (mean ± S.E. 444
± 26 vs. 299 ± 34, p < .001). Surprisingly, cyclooxygenase activity
was significantly elevated in static control cultures by
cycloheximide after both 4-5 h and 20-22 h of incubation (Table i).
In 4 separate experiments, cycloheximide increased cyclooxygenase
activity by 56% to 220%. Similar results were obtained when RNA
synthesis was inhibited with 1.0 _M actinomycin D (data not shown).
This elevated enzymatic activity was sensitive to inhibition by the
cyclooxgenase inhibitor indomethacin (Table i, Experiment 3). PGF2=
production from endogenous arachidonic acid over a 12 h period was
increased two-fold by 70 _M cycloheximide. PGF2,/mg protein
increased from a mean ± S.E. of 71 ± 12 to 220 ± 55 (n=4, P < .04).
Following a 1 h preincubation in 70 _M cycloheximide at 37°C,
the cells were mechanically stimulated for 4-24 h in the presence
of cycloheximide and cyclooxygenase activity measured during the
last 30 min with 30 _M exogenous arachidonic acid. After 4-5 h of
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mechanical stimulation, cyclooxygenase activity was still
significantly increased compared to static controls (Figure 6). At
20-24 h, cyclooxygenase activity was not significantly greater than
static control levels, but this was primarily due to the elevated
control values in the cycloheximide-treated cultures at the longer
incubation periods (Figure 6).
Since the differentiated myofibers are spontaneously
contractile, it is important to distinguish between a direct
mechanical effect on cyclooxgenase activity and an indirect
mechanically-induced alteration in myofiber electrical activity. We
have shown previously that stretch-induced PGF2. production is not
inhibited by tetrodotoxin, a voltage-sensitive sodium channel
inhibitor which completely blocks all contractile activity in the
cultures. Tetrodotoxin also had no significant effect on either
control or stretch-activated cyclooxygenase activity (Figure 7).
Whereas tetrodotoxin was ineffective in preventing stretch-induced
prostaglandin production (34) or cyclooxygenase activity, the G
protein inhibitor pertussis toxin inhibited both stretch-induced
PGF2. production (Figure 8A) and cyclooxygenase activation (Figure
8B). In addition, pertussis toxin inhibited the stretch-induced
increase in noncollagenous protein (Figure 8C) associated with
myofiber hypertrophy (33).
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DISCUSSION
The major finding in this report is that repetitive mechanical
stretching of differentiated skeletal muscle cultures increased the
production of PGF2., an anabolic growth modulator, by increasing the
activity of cyclooxygenase, an important regulatory enzyme in
prostaglandin synthesis. Stretch activation of cyclooxygenase
occurred by a posttranslational mechanism based on two lines of
evidence: (i) decreased cyclooxygenase K. with no change in V_x; and
(2) cycloheximide insensitivity. The stretch-induced increases in
PGF2_ production and cyclooxygenase activity, as well as the
increase in protein accumulation, were inhibited by pertussis
toxin. Thus, these stretch-related growth responses involve
mechanically-activated G proteins of the Gi or Go subtype.
Repetitive stretch of these cells also activates several specific
phospholipases (A2 and D) (38) which provide endogenous arachidonic
acid for cyclooxygenase conversion into prostaglandins. Thus,
mechanical cell stretching appears to activate a cascade of steps
involved in the generation of lipid-related mechanogenic second
messengers which regulate skeletal muscle growth.
Cyclooxygenase exists in two isoforms (24,41), one of which is
a mitogen-inducible, immediate-early gene product (5,26). The
cyclooxygenase isoform which is activated by stretch in the
skeletal muscle cultures is not known, but may be the mitogen-
inducible isoform, based on several lines of evidence. First, the
mitogen-inducible isoform is approximately 25 fold less sensitive
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to indomethacin inhibition than the constitutive isoform _, and high
concentrations of indomethacin are required to inhibit stretch-
activated cyclooxygenase activity in the skeletal muscle cultures
(34). Secondly, greater than 90% of the stretch-induced
prostaglandin production in these cultures comes from the skeletal
myofibers rather than the fibroblasts (38). Immunocytochemical
staining of the cultured skeletal muscle cells indicate that the
skeletal myofibers contain high levels of the mitogen-inducible
cyclooxygenase isoform when compared to neighboring mononucleated
fibroblasts (Figure 4). Other immediate-early gene products,
especially the protooncogenes, have been shown to be associated
with cardiac muscle hypertrophy (28) and are stretch-activated
(14,25). If the mitogen-inducible isoform of cyclooxygenase is
stretch-activated in skeletal muscle and responsible for increased
PGF2, production, it would be the first demonstration of an
immediate early gene product involved in cell hypertrophy with a
well defined function.
Cyclooxygenase in adult rat skeletal muscle has been reported
to be an extremely rapidly turning over protein, with a half-life
of less than i0 min, based on rapid inhibition of enzymatic
activity in organ cultures with either cycloheximide or actinomycin
D (4). In contrast, other studies with adult rat skeletal muscle
organ cultures have reported no effect of cycloheximide on
cyclooxygenase activity for at least 2 h (16). Direct measurement
of human dermal fibroblast cyclooxygenase turnover indicated a one
ICayman Chemical Co. product literature.
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hour half-life (21). In the present study, it was surprising that
neither cycloheximide nor actinomycin D inhibited cyclooxygenase
activity in cultured skeletal muscle over a 20-24 h incubation
period under conditions where protein synthesis was inhibited by
87-93% (Table I). In fact, cyclooxygenase activity was
significantly elevated by an indomethacin-sensitive mechanism when
protein synthesis was inhibited. If the enzyme in these cells had
a half-life of one hour or less, little activity should remain
after 4 h or longer incubations in cycloheximide. The reason for
the discrepancy in cyclooxygenase half life and the effects of
protein synthesis inhibition in different experiments is not known,
but may reflect greater cyclooxygenase stability in skeletal muscle
versus fibroblasts (21), age-related differences in skeletal muscle
[neonatal muscle in this study versus adult muscle in (4)] or the
conditions under which the cyclooxygenase was assayed [isometric in
this study versus hypercontracted organ culture in (4)]. More
direct measurement of cyclooxygenase half-lives in the myofibers
will be required to resolve this question. Cycloheximide activation
of cycooxygenase activity in these cells may occur by inhibition of
a rapidly turning over negative regulator of the enzyme.
Stretch-induced myofiber hypertrophy and prostaglandin
production were shown previously to be independent of cell
electrical activity i.e. tetrodotoxin-insensitive (33,34).
Likewise, the present paper indicates that stretch-activated
cyclooxygenase activity is tetrodotoxin-insensitive (Figure 7). In
contrast, stretch-induced increases in protein content,
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prostaglandin production, and cyclooxygenase activity are inhibited
by pertussis toxin (Figure 8), indicating involvement of stretch-
sensitive G proteins of the _, or ao subclass. While G proteins are
known to regulate prostaglandin synthesis through their control of
phospholipase activities (12), this is the first report of their
involvement in also regulating cyclooxygenase enzymatic activity.
There are several mechanisms by which G proteins could
regulate mechanically-induced skeletal muscle growth and
prostaglandin synthesis. Stretch increases the sensitivity of
muscle cells to exogenous anabolic growth factors such as insulin
and insulin-like growth factor-I (30,36) whose receptors are G
protein-coupled (ii). Pertussis toxin may uncouple this signal
transduction pathway. Secondly, muscle cell growth is influenced by
calcium levels (I0), and stretch is known to regulate ionic fluxes
in skeletal muscle (37). G proteins may regulate stretch-activated
ionic channels important for regulating intracellular calcium
levels (1,12,13). Stretch-activated PG production in these cells is
partially dependendent on extracellular calcium (38).
In summary, mechanical stimulation of tissue cultured skeletal
muscle stimulates the activity of cyclooxgenase, the major
regulatory enzyme in PGF2. production, an anabolic growth factor for
skeletal muscle cells. This activation occurs by a
posttranslational, G-protein dependent mechanism. Understanding
which G proteins are mechanically-sensitive and involved in
regulating anabolic growth modulators such as prostaglandins in
skeletal muscle will aid in understanding how muscle
17
stretch tension exercise regulates muscle cell size.
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TABLE I
Protein Synthesis Inhibition Stimulates Cyclooxygenase Activity
In Skeletal Muscle Cultures
,periment Incubation
Time
(hours)
4
21
22
Cycloheximide
(70 _S)
+
I
+
m
+
+
Indomethacin
m
+
Activity
(ng PGF2_/mg
protein)
0.24 ± 0.03
0.44 ± 0.07"
0.30 + 0.04
0.81 + 0.15""
0.83 + 0.09
2.65 + 0.12""
0.54 + 0.03
"P<.01 "*P<.02 **'P<.001
%4
85%
165%
220%
35%
Day 6-7 muscle cultures were incubated for 4-22 h with or without
70 _M cycloheximide and cyclooxygenase activity measured over a 30
min period with 30 _M exogenous arachidonic acid as outlined in the
text. In experiment 3, i00 BM indomethacin was added 3 h prior to
the addition of cycloheximide. Cycloheximide did not interfere with
the ELISA assay used to measure PGF2. (data not shown). Each value
i
is the mean ± S.E.of 4-6 samples.
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FIGURE LEGENDS
Figure i. Diagrammatic representation of the modified mechanical
cell stimulator. (A) The stainless steel cell growth chamber
contains 36 teflon-lined culture wells 15 mm in diameter; (B) 2 mm
diameter prongs move up and down to stretch and relax the cells;
(C) "diaphragm-like" tissue samples attach and are stretched while
attached to stainless steel wire cloth at the periphery of each
well; (D) the computer-generated pattern of mechanical activity
used to stimulate PG synthesis and cyclooxygenase activity. Bar in
A equals 3.0 cm.
Figure 2. Intermittent mechanical stimulation increases PGF2_
production in skeletal muscle cultures. Seven days postplating
cultures were mechanically stimulated by TRIAL 51.PGM activity
program (Figure ID) at different intensities (percent stretch) in
serum-free defined medium for 24 h. Percent stretch was varied
between groups of wells in the same experiment by using prongs of
different heights. PGF2_ levels in the medium were assayed as
described in MATERIALS AND METHODS. Results are expressed as pg/mg
total noncollagenous protein and each point represents the mean ±
SE of 5-6 samples. Statistical analysis was by t-tests for unpaired
values.
Figure 3. Cyclooxygenase immunocytochemical localization in
skeletal myofibers. Day 7-8 cultured cells were fixed and stained
with either hematoxylin and eosin (upper), preimmune serum
28
(middle), or anti-cyclooxygenase antibody (mitogen-inducible) as
outlined in MATERIALS AND METHODS(lower).
Figure 4. Intermittent mechanical stimulation increases
cyclooxygenase activity in intact cells. Seven to eight day
postplating cultures were mechanically stimulated by TRIAL 51.PGM
activity program for 5-24 h in serum-free medium. Thirty BM
exogenous arachidonic acid was added in fresh serum-free medium for
the last 30 min of incubation to either static control wells (O)
or mechanically stimulated wells ( • ). PGF2_ levels were measured
in an aliquot of the medium. Total noncollagenous protein
concentrations are within 10% of each other in control and
mechanically stimulated cultures. The upper left insert shows that
PGF2_ synthesis from 30 _M arachidonic acid in static muscle
cultures was linear for at least 60 min (0) and that no detectable
PGF2_ was synthesized during the 30 min incubation in the absence
of exogenous arachidonic acid (V). The upper right insert shows
that 30 _M exogenous arachidonic acid maximally stimulated PGF2_
synthesis during a 30 min assay period. The bottom left insert
shows that cyclooxygenase inhibitors indomethacin (O), aspirin (_
), or ibuprofen ( _ ) inhibit cyclooxygenase activity in a dose-
dependent manner in this iD situ assay. Each point is the mean ± SE
of 4-6 samples and statistical analyzing was by unpaired t-tests.
•P<.003; "'P<.002.
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Figure 5. Kinetics of stretch-induced alterations in cyclooxygenase
activity. Seven to eight day postplating cultures were mechanically
stimulated by TRIAL 51.PGM activity program for 4 (A) or 24 h (B)
in serum-free medium. Varying concentrations of exogenous
arachidonic acid were added in fresh serum-free medium for the last
30 min of incubation to either static control wells ( O ) or
mechanically stimulated wells (0). Each point is the mean ± SE of
4-6 samples and statistical analyzing was by unpaired t-tests.
Figure 6. Stretch increases cyclooxygenase activity in the presence
of cycloheximide. Day 7-8 postplating muscle cultures were rinsed
in serum-free medium for 1-2 h as outlined in MATERIALS AND METHOD
with or without 70 _M cycloheximide (CHX). Mechanical stimulation
by TRIAL51.PGM was initiated for 4-24 h ± CHX. Fresh serum-free
medium was added ± CHX containing 30 _M arachidonic acid for 30 min
and an aliquot of the medium assayed for PGF2_. The values are the
mean ± SE of 4-6 samples per group and statistical analyses were by
unpaired t-tests.
Fiaure 7. Intermittent mechanical stimulation increases
cyclooxygenase activity in electrically quiescent muscle cultures.
Day 7-8 postplating muscle cultures were rinsed in serum-free
medium for 2 h as outlined in MATERIAL AND METHODS with 1 _g/ml
tetrodotoxin (TTX) in some wells. Mechanical stimulation by
TRIAL51.PGM activity program was initiated for 24 h ± TTX. Fresh
serum-free medium was added ± TTX containing 30 _M arachidonic acid
30
for 30 min and an aliquot of the medium assayed for PGF2_. Total
noncollagenous protein concentrations were within 20% in the
different experimental groups. The values are the mean ± SE of 5-6
samples and statistical analyses were by unpaired t-tests.
Figur@ 8. Stretch-stimulated PGF2_ production, cyclooxygenase
activity and protein accumulation are pe_tussis toxin-sensitive.
Six to seven day postplating cultures were preincubated overnight
with or without i00 ng/ml pertussis toxin, rinsed, and mechanical
stimulation (TRIAL 51.PGM) initiated for 24 h with or without
pertussis toxin. CA_ PGF_. productiQn. The 24 h culture medium was
collected and assayed for PGF2. production by ELISA.
Cyclooxygenase activity. Fresh medium containing 30 _M arachidonic
acid was added for the last 30 min of incubation and PGF2_
production assayed. (C) Total noncollagenous cellular protein in
the different groups was assayed as outlined in MATERIALS AND
METHODS. Each bar represents 4-6 samples ± S.E. and statistical
analyses are by unpaired t-tests. IAP, pertussis toxin
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